期刊文献+

系统性红斑狼疮与补体的相关性研究概况 被引量:9

下载PDF
导出
摘要 以补体激活途径为切入点,分别从系统性红斑狼疮与C1q及抗C1q抗体,与C3、C4,与MBL,与补体因子H,与补体调节蛋白的关系,探讨近年来系统性红斑狼疮与补体的相关性的研究方向和现状,从而了解补体在系统性红斑狼疮中的作用机制,为今后进一步研究系统性红斑狼疮发生、发展及预后提供一定的科研思路与方法,以及更好地提高其临床疗效。
出处 《风湿病与关节炎》 2015年第3期55-59,共5页 Rheumatism and Arthritis
基金 国家中医药重点学科中医痹病学建设项目(国中医药发〔2009〕30号)
  • 相关文献

参考文献40

  • 1曹雪涛.医学免疫学[M].6版.北京:人民卫生出版社,2013:57.
  • 2周滨,张奉春,董怡.补体C1q及抗C1q抗体与系统性红斑狼疮及狼疮肾炎相关性的研究[J].中华风湿病学杂志,2005,9(12):725-728. 被引量:23
  • 3Lood C,Eriksson S,Gullstrand B,et al.Increased Clq,C4 and C3 deposition on platelets in patients with systemic lupus erythematosus-a possible link to venous throm- bos? [ J ] .Lupus,2012,21 ( 13 ) :1423-1432.
  • 4冯江超,青玉凤,周京国.血清抗C1q抗体在系统性红斑狼疮疾病活动性判断及狼疮肾炎诊断中的价值[J].免疫学杂志,2010,26(3):228-231. 被引量:6
  • 5Carlos GM,lsabella L,Mittermayer BS,et al.Anti-Clq antibodies:association with nephritis and disease activ- ity in systemic lupus erythematosus[ J ] .J Clin Lab Anal,2009,23 ( 1 ) :19-23.
  • 6Chen Z,Wang GS,Wang GH,et al.Anti-Clq antibody is a valuable biological marker for prediction of renal pathological characteristics in lupus nephrits [ J ] .Clin- ical Rheumatology,2012,31 ( 9 ) :1323-1329.
  • 7李就鸿,张军,黄佩珍,蒋莹.抗C1_q抗体与系统性红斑狼疮疾病活动及狼疮肾炎的关系[J].中华全科医学,2013,11(7):1039-1040. 被引量:4
  • 8Akhter E,Burlingame RW, Seaman AL,et al.Anti-Clq antibodies have higher correlation with flares of lupus nephritis than other serum markers [ J ] .Lupus,2011,20 ( 12 ) :1267-1274.
  • 9Trad B,Ben Hassine H,Khalifa M,et al.Anti-Clq an- tibodies and systemic lupus erythematosus in the Tu- nisian population [ J] .Pathol Biol ( Paris ) ,2013,61 (3) :113-116.
  • 10Smykat-Jankowiak K,Niemir ZI,Polcyn-Adamczak M.Do circulating antibodies against Clq reflect the activity of liapus nephritis? [ J ] .Pol Arch Med Wewn, 2011,121 ( 9 ) :287-295.

二级参考文献261

共引文献134

同被引文献79

  • 1陆煜,卿国忠.免疫调理治疗改善脓毒症炎症因子、体液和细胞免疫以及预后的作用[J].医学信息(医学与计算机应用),2014,0(30):61-62. 被引量:3
  • 2徐亮,王元,陈顺乐.系统性红斑狼疮重症血小板减少患者血清对巨核祖细胞的影响[J].现代免疫学,2005,25(1):56-60. 被引量:6
  • 3Arkfeld DG,Weitz IC.Immune thrombocytopenia in pa- tients with connective tissue disorders and the antiphos- pholipid antibody syndrome [ J ] .Hematol Oncol Clin North Am,2009,23 ( 6 ) :1239-1249.
  • 4Lood C,Tyd:n H,Gultstrand B,et al.Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus [ J : .PLoS One,2014,9 ( 6 ) :e99386.
  • 5Bashal F.Hematological disorders in patients with sys-temic lupus erythematosus E J ] .Open Rheumatol J,2013 ( 7 ) :87-95.
  • 6Ho A,Barr SG,Magder LS,et al.A decrease in com- plement is associated with increased renal and he- matologic activity in patients with systemic lupus erythematosus I J ] .Arthritis Rheum,2001,44 ( 10 ) : 2350-2357.
  • 7Yehudai D,Toubi E,Shoenfeld Y,et al.Autoimmunity and novel therapies in immune-mediated thrombocyto- penia : J ] .Semin Hematol,2013,50 Suppl 1:S100-108.
  • 8Fiireder W,Firbas U,Nichol JL,et al.Serum thrombo- poietin levels and anti-thrombopoietin antibodies in systemic lupus erythematosus E J ] .Lupus,2002,11 ( 4 ) :221-226.
  • 9Kam T,Alexander M.Drug-induced immune thrombo- cytopenia [ J ] .J Pharm Pract,2014,27 ( 5 ) :430-439.
  • 10Rinaldi M,Perricone C,Ortega-Hernandez OD,et al.Im- mune thrombocytopaenic purpura:an autoimmune cross-link between infections and vaccines [ J ] .Lu- pus,2014,23 ( 6 ) :554-567.

引证文献9

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部